Why Randomized Trials for Proton Therapy Are Difficult to Complete (And What We Can Do About It)
Perelman School of Medicine at the University of PennsylvaniaCommercial insurance medical policies that do not cover treatment with proton therapy can make it difficult for patients to participate in randomized clinical trials funded by the NCI, part of the National Institutes of Health, that are evaluating the therapy.